fosrenol
Head-to-head trial favours Shire’s Fosrenol
October 8, 2009Research and Development, Sales and Marketing fosrenol, renal
Shire's Fosrenol could have a clinical advantage over rival drug Renagel from Genzyme, according to the results of what is …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
